Crowdonomics
This isn’t Regen BioPharma Inc’s most recent raise. Reg A+ · Equity · Nov 2025 (Open) is more current.View latest round
Regen BioPharma Inc

Private · Common Stock · Mar 2023

ClosedOtherCommon Equity
via the platform · last checked Sep 24, 2026
Raised
$335.4K
Investors
Estimated pre-money
$7.8B

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Deal terms

Est. pre-money$7.8B
Price / share$1.36

Estimated, not stated: $1.36 × 5,701,140,784 securities outstanding as of Jan 17, 2023 (Form 10-Q filed Jan 19, 2023, p. 1).

Down round. Priced 53% below Section 4(a)(2) Private Offering (2016) (Jun 2016) on a split-adjusted basis: $1.36 vs $2.9095 a share in today's terms — a conversion or split sits between the two, so check its ratio on the earlier round.

Offering details

Target
Max
Min investment
OpenedMar 6, 2023
Deadline
ClosedFeb 21, 2024
Days active352

Links & provenance

Source: SEC EDGAR
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.